2024 VEITHsymposium - Faculty Detail

Tuesday, November 18 - Saturday, November 22, 2025

VEITHsymposium
GEORGE A. ANTONIOU, MD, PHD, MSC, FEBVS
MAHSC Honorary Clinical Professor
The University of Manchester

Consultant Vascular and Endovascular Surgeon
Manchester University NHS Foundation Trust

Manchester, United Kingdom
SCHEDULE FOR VEITHsymposium™
Tuesday, November 19, 2024
Presenter
SESSION 5: NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) ETIOLOGY, DETECTION, TREATMENT AND EVAR

DEBATE: Patient Survival After EVAR Was NOT Improved By Compliance With Surveillance Protocols: The EVAR Surveillance Paradox: From A Systematic Meta-Analysis: What Is The Explanation
1:18 PM - 1:23 PM

View Slides in PDF


Wednesday, November 20, 2024
Presenter
SESSION 46: MORE SHORT HOT NEW TOPICS RELATED TO AORTC DISEASE AND ITS TREATMENT

Why EVAR Should Be Preferred Over Open Repair In Young Patients With Suitable Anatomy: From A Meta-Analysis Of >50,000 Patients
4:54 PM - 4:59 PM

View Slides in PDF


Presenter
SESSION 43: MORE NEW DEVELOPMENTS IN AAA TREATMENT AND STANDARD EVAR: A NEW DEVICE TO SLOW AAA GROWTH; AAA NECK DILATATION AFTER EVAR; VALUE OF LOW PROFILE AAA ENDOGRAFTS; IMPROVED ULTRASOUND SURVEILLANCE AND ALL AAAS ARE NOT TIME BOMBS WAITING TO EXPLODE

EVAR Patients On Anticoagulation Have Increased Mortality, Endoleaks, Sac Expansion And Reinterventions: From A Meta-Analysis Of >35,000 Patients
1:18 PM - 1:23 PM

View Slides in PDF


Saturday, November 23, 2024
Presenter
SESSION 108: AORTIC TOPICS TOO IMPORTANT TO MISS AND SPINE EXPOSURE

Outcomes Of EVAR In Over 18,000 High-Risk Patients Ineligible For Open Repair: When Is EVAR Justified Over No Intervention In Such Patients: Why Is EVAR 2 No Longer Relevant
10:00 AM - 10:05 AM

View Slides in PDF